Summary
Federal regulations governing Medicare-funded pathology services, including the Pathology Services Table, accreditation requirements for pathology providers, restrictions on who may request pathology tests, and fee structures for bulk-billed services. The instrument was registered on 29 May 2009 as an amendment to the principal Health Insurance (Pathology Services) Regulations.
Reason
These regulations represent centralized price controls and supply restrictions in pathology services, artificially constraining supply through provider accreditation barriers and limiting who can request tests. The compliance burden adds costs that are passed on to consumers, while price fixing through the Medicare Benefits Schedule prevents the natural price competition that would lower costs and improve access. Pathology services, as a diagnostic input to healthcare, would function more efficiently with fewer regulatory constraints, allowing market signals to determine service availability, pricing, and innovation. The amendment layer onto an already heavily regulated sector, compounding compliance costs with negligible demonstrated benefit to diagnostic outcomes.